相关实验视频
Updated: Jun 6, 2026

11:19
Oral Biofilm Formation on Different Materials for Dental Implants
Published on: June 24, 2018
11.6K
未能更换被删除的增长友好型植入物导致放射性结果恶化
Matan S Malka1, Lawrence G Lenke2, Ritt R Givens2
1Department of Pediatric Orthopaedic Surgery, Morgan Stanley Children's Hospital of New York Presbyterian, Columbia University Medical Center, 3959 Broadway, CHONY 8-N, New York, NY, 10032-3784, USA. msm2244@cumc.columbia.edu.
Spine deformity
|July 4, 2025
概括
在早期开始的脊髓形 (EOS) 患者中,在切除后迅速重新植入增长友好的结构,稳定脊柱曲线. 建议早期重新植入以改善结果,尽管存在手术挑战.
科学领域:
- 儿科整形外科 儿科整形外科
- 脊柱外科手术 脊柱外科手术
- 脊椎病研究 脊椎病研究
背景情况:
- 早期脊柱形脊柱病 (EOS) 的管理通常需要对儿童进行增长友好的手术,这些孩子还没有准备好进行最终的融合.
- 关于在EOS患者中移除植入物 (ROI) 后的结果的数据有限,这些患者的生长结构失败了.
研究的目的:
- 为了比较早期重新植入的结果与EOS患者的生长友好的植入物被移除后的观察.
- 评估重新植入时间对脊柱曲线进展的影响.
主要方法:
- 来自国际登记处的EOS患者进行了回顾性分析,这些患者正在接受植入物切除.
- 早期重新植入 (在12个月内) 与仅观察组的比较.
- 放射测量 (冠状科布角) 分析了切除前后的情况.
主要成果:
- 观察组在ROI后两年显示出显著更大的冠状科布角增加 (81°对53°,p=0.003).
- 在重新植入组中,较少的患者经历了显著的曲线进展 (30%对64%,p=0.04).
- 重新植入组保持了曲线稳定性,从即时后ROI到两年没有显著的进展.
结论:
- 快速重新植入增长友好的植入物有效地稳定了EOS患者的脊柱曲线.
- 及时重新植入对于优化这种患者群体的结果至关重要.
- 建议在可行的情况下优先重新植入,尽管存在潜在的技术困难.
相关概念视频
Mismatch Repair
Overview
Mismatch Repair
Organisms are capable of detecting and fixing nucleotide mismatches that occur during DNA replication. This sophisticated process requires identifying the new strand and replacing the erroneous bases with correct nucleotides. Mismatch repair is coordinated by many proteins in both prokaryotes and eukaryotes.
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
Bone Marrow Sampling and Transplants
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...

